Pfizer Expects To File 12 "Major" NDAs By The End Of 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
The company's strategy to weather upcoming patent expirations includes plan to file 20 NDAs over the five-year period ending 2006, U.S. Pharmaceuticals President Pat Kelly tells investors.